Loading...
Docoh

Burning Rock Biotech (BNR)

Burning Rock Biotech Limited, whose mission is to guard life via science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology. Its business consists of i) NGS-based therapy selection testing for late-stage cancer patients, with the leading market share in China and over 273,000 tissue and liquid-based tests completed cumulatively, and ii) cancer early detection, which has moved beyond proof-of-concept R&D into the clinical validation stage.

BNR stock data

Calendar

29 Apr 22
12 Aug 22
Quarter (USD) Dec 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
56.5% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 5 5
Opened positions 0 1 EXIT
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 2 EXIT
13F shares Current Prev Q Change
Total value 869.19M 869.19M
Total shares 49.62M 49.62M
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners Shares Value Change
Han Yusheng 17.32M $400.2M 0.0%
Northern Light Venture Fund III 11.88M $274.43M 0.0%
Lyfe Capital Management 8.34M $79.47M 0.0%
CMB International Capital 7.03M $66.97M 0.0%
Right Lane 5.05M $48.11M 0.0%
Largest transactions Shares Bought/sold Change
Northern Light Venture Fund III 11.88M 0 0.0%
Han Yusheng 17.32M 0 0.0%
Right Lane 5.05M 0 0.0%
CMB International Capital 7.03M 0 0.0%
Lyfe Capital Management 8.34M 0 0.0%

Content analysis

?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
Proxies
No filings